sales
Zytiga is powerhouse for J&J – but for how long?
J&J to ‘vigorously defend’ blockbuster’s patent
Pharma marketing requires a global approach
The industry must update its strategy for the digital age.
No dishonest dealing in our sales reports, says Alexion
Shares rise following announcement.
Vericel hopes for US hit with Maci knee treatment
Tissue engineering product previously flopped in EU.
